Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FHQ7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,143
Award facts
- Contract value 100% obligated
- $38,143.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract valued at $38,143.17, with completion required by December 22, 2025. This non-set-aside award represents a competitive procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This Jardiance delivery order reflects the company's ongoing role in fulfilling diabetes medication requirements for the military healthcare supply chain through the DLA's Pharmaceutical Prime Vendor program, which strategically employs multiple vendor agreements to ensure reliable access to essential medical commodities.
Quick answers
Who was awarded contract SPE2DR26FHQ7U?
SPE2DR26FHQ7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FHQ7U worth?
The government has obligated $38,143 on SPE2DR26FHQ7U.
Is contract SPE2DR26FHQ7U an order under another contract?
Yes. SPE2DR26FHQ7U is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHQ7U competed?
The extent of competition for SPE2DR26FHQ7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award